The Secondary Metabolites from Genus Kitasatospora : A Promising Source for Drug Discovery
Chemistry & Biodiversity · 2024
DOI: 10.1002/cbdv.202401473 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chemistry & Biodiversity, 2024. Verfasst von Yuanjuan Wei und 3 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Medicinal Biotechnology, Chinese Academy of Medical Scien…. Hauptthemen laut MEDLINE: Drug Discovery, Biological Products. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 93 Literaturangaben. Gefördert von: National Natural Science Foundation of China, CAMS Innovation Fund for Medical Sciences, 2021-I2M-1-005.
Abstract (Originalsprache)
Microbial secondary metabolites are well‐known resource for drug discovery. Kitasatospora is one of the rare genera of Actinomycetes and important antibiotics producer that are not fully explored. Recently an explosively increasing number of reports have proved that the genus is capable of producing various bioactive secondary metabolites. Here, we comprehensively summarized secondary metabolites from Kitasatospora strains including their chemical structures, biological effects, mechanisms of actions together with the related genomic and biosynthetic analyses. The review covered more than 100 metabolites with their significant pharmacological properties. Some of these natural products which include tyropeptin has been optimized to a promising lead compound. This work provides detailed information of Kitasatospora ‐derived natural products and presents their potential for therapeutically relevant utilization, which would inspire the drug discovery from this genus in future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100050, China.
ORCID-Profile: Guiyang Wang
Förderung
- National Natural Science Foundation of China
- CAMS Innovation Fund for Medical Sciences
- 2021-I2M-1-005
Zitieren
APA
Wei, Y., Wang, G., Li, Y., & Gan, M. (2024). The Secondary Metabolites from Genus Kitasatospora : A Promising Source for Drug Discovery. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202401473
Vancouver
Wei Y, Wang G, Li Y, Gan M. The Secondary Metabolites from Genus Kitasatospora : A Promising Source for Drug Discovery. Chemistry & Biodiversity. 2024. doi:10.1002/cbdv.202401473
BibTeX
@article{Wei2024,
author = {Wei, Yuanjuan and Wang, Guiyang and Li, Yan and Gan, Maoluo},
title = {The Secondary Metabolites from Genus Kitasatospora : A Promising Source for Drug Discovery},
journal = {Chemistry & Biodiversity},
year = {2024},
doi = {10.1002/cbdv.202401473}
}
EUVIMED